- Report
- March 2025
- 547 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 175 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- November 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- July 2024
- 135 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- January 2025
- 181 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 186 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 183 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- July 2024
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- August 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- July 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- May 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- May 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- July 2024
- 200 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- July 2024
- 155 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- July 2024
- 151 Pages
Global
From €4040EUR$4,250USD£3,394GBP
From €7130EUR$7,500USD£5,990GBP

A xenograft is a type of biotechnology that involves the transplantation of tissue from one species to another. It is commonly used in medical research and in the development of new treatments for diseases. Xenografts are also used in the production of therapeutic proteins, such as antibodies, and in the production of cell-based therapies.
The xenograft market is a rapidly growing sector of the biotechnology industry. It is driven by the increasing demand for new treatments for diseases, as well as the need for more efficient and cost-effective production of therapeutic proteins and cell-based therapies. The market is also driven by advances in technology, such as gene editing and stem cell research, which have enabled the development of more sophisticated xenografts.
Some of the major companies in the xenograft market include Novartis, Pfizer, Merck, and Amgen. These companies are involved in the development and production of xenografts for medical research and therapeutic applications. Other companies in the market include AbbVie, AstraZeneca, and Regeneron. Show Less Read more